News Roche hopes blood test will predict immunotherapy efficacy Test could help determine which patients respond to immunotherapies.
News FDA probes blood cancer immunotherapy safety Regulator reviewing combination therapy safety after issue with Keytruda
News BMS snaps up cancer biotech IFM in $2.3bn deal BMS will gain rights to preclinical cancer immunotherapy drugs.
Views & Analysis Immunotherapies in oncology: the future of cancer treatment ... Partnerships, co-marketing and the positioning of drugs are shaping the competitive landscape in oncology.
News The week that turned the cancer immunotherapy market on its ... Contrasting fortunes for Roche and AZ in a week of drama.
News Pfizer chief suggests no BMS bid - for now Ian Read won't quash rumours that his company Pfizer could swoop for vulnerable Bristol-Myers Squibb - but says it won't make any major acquisitions
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
